These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16407588)

  • 81. Lipid peroxidative processes in liver damage and steatosis.
    Placer Z; Vidláková M; Kuzela L
    Rev Czech Med; 1970; 16(1):29-39. PubMed ID: 5436335
    [No Abstract]   [Full Text] [Related]  

  • 82. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice.
    Letteron P; Fromenty B; Terris B; Degott C; Pessayre D
    J Hepatol; 1996 Feb; 24(2):200-8. PubMed ID: 8907574
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of hepatitis B virus infection on hepatic metabolic signaling pathway.
    Shi YX; Huang CJ; Yang ZG
    World J Gastroenterol; 2016 Sep; 22(36):8161-7. PubMed ID: 27688657
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Drug therapy for nonalcoholic fatty liver disease].
    Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):114. PubMed ID: 12648414
    [No Abstract]   [Full Text] [Related]  

  • 85. Zonation of hepatic fatty acid metabolism - The diversity of its regulation and the benefit of modeling.
    Schleicher J; Tokarski C; Marbach E; Matz-Soja M; Zellmer S; Gebhardt R; Schuster S
    Biochim Biophys Acta; 2015 May; 1851(5):641-56. PubMed ID: 25677822
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Peroxisomal fatty acid metabolism, peroxisomal proliferator-activated receptors and non-alcoholic fatty liver disease.
    Macdonald GA; Prins JB
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1335-7. PubMed ID: 15610304
    [No Abstract]   [Full Text] [Related]  

  • 87. [Liver steatosis and lipid peroxidation].
    Kuzela L; Placer Z
    Cesk Gastroenterol Vyz; 1968 Sep; 22(6):380-3. PubMed ID: 5681922
    [No Abstract]   [Full Text] [Related]  

  • 88. [Behavior of lipid classes and fatty acids in different stages of alcoholic liver disease].
    Marzo A; Ghirardi P
    Recenti Prog Med; 1971 Nov; 51(5):409-19. PubMed ID: 5172395
    [No Abstract]   [Full Text] [Related]  

  • 89. [The effect of silymarin on lipids in the blood and liver in steatosis].
    Ulicná O; Brixová E
    Vnitr Lek; 1985 Jan; 31(1):15-9. PubMed ID: 3969785
    [No Abstract]   [Full Text] [Related]  

  • 90. [Model of isolated hepatocytes in the study of hepatic steatosis].
    Dianzani MU; Poli G; Gravela E; Chiarpotto E; Albano E
    Minerva Chir; 1982 Feb; 37(4):235-6. PubMed ID: 7088316
    [No Abstract]   [Full Text] [Related]  

  • 91. Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease.
    Rabinowich L; Shibolet O
    Biomed Res Int; 2015; 2015():168905. PubMed ID: 26273591
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hepatic steatosis in children.
    Colon AR
    Am J Gastroenterol; 1977; 68(3):260-9. PubMed ID: 413433
    [No Abstract]   [Full Text] [Related]  

  • 93. Studies on fatty liver with isolated hepatocytes. II. The action of carbon tetrachloride on lipid peroxidation, protein, and triglyceride synthesis and secretion.
    Poli G; Gravela E; Albano E; Dianzani MU
    Exp Mol Pathol; 1979 Feb; 30(1):116-27. PubMed ID: 421862
    [No Abstract]   [Full Text] [Related]  

  • 94. The interaction of hepatic lipid and glucose metabolism in liver diseases.
    Bechmann LP; Hannivoort RA; Gerken G; Hotamisligil GS; Trauner M; Canbay A
    J Hepatol; 2012 Apr; 56(4):952-64. PubMed ID: 22173168
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Decrease of lipid infiltration of the rat liver by beta-pyridyl-carbinol].
    Gey KF; Lorch E
    Helv Physiol Pharmacol Acta; 1966; 24(2):C22-4. PubMed ID: 5973815
    [No Abstract]   [Full Text] [Related]  

  • 96. In vitro hepatic steatosis model based on gut-liver-on-a-chip.
    Jeon JW; Lee SH; Kim D; Sung JH
    Biotechnol Prog; 2021 May; 37(3):e3121. PubMed ID: 33393209
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Action of (+)-catechin on experimental liver steatosis in the white rat].
    Gajdos A; Gajdos-Török M; Horn R
    C R Seances Soc Biol Fil; 1970; 164(10):1967-70. PubMed ID: 4327136
    [No Abstract]   [Full Text] [Related]  

  • 98. Hepatic steatosis: innocent bystander or guilty party?
    Day CP; James OF
    Hepatology; 1998 Jun; 27(6):1463-6. PubMed ID: 9620314
    [No Abstract]   [Full Text] [Related]  

  • 99. Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis.
    Méndez-Sánchez N; Córdova-Gallardo J; Barranco-Fragoso B; Eslam M
    Front Immunol; 2021; 12():641240. PubMed ID: 33833761
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Absorption of triolein-I 131 and oleic acid- I 131 in hepatic diseases (obstructive jaundice, cirrhosis, steatosis and cancer of the liver].
    Afifi F; Boivin P
    Rev Int Hepatol; 1967; 17(5):411-21. PubMed ID: 6056142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.